InsidersTradesSigma
Total declarations
Companies
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
12
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-7.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Collard Craig A, Director. Officer active across 4 companies, notably Opiant Pharmaceuticals, INC.. Cumulatively, 37 reports have been logged. Split: 12 buys · 0 sell. Total volume traded: €1.1m. Activity tracked since 15 June 2021. The latest transaction was filed on 25 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations37 total
13,797 sharesCommon StockSEC:0001193125-26-165365:0
13,797 sharesCommon StockSEC:0001193125-25-244520:0
13,797 sharesCommon StockSEC:0000950170-25-097488:0
34,789 sharesCommon StockSEC:0000950170-25-063061:0
13,796 sharesCommon StockSEC:0000950170-25-056488:0
62,500 sharesCommon StockSEC:0000950170-25-050677:0
2,258 shares@ US$0.460.3% of flowCommon SharesSEC:0001415889-25-009042:0
13,797 sharesCommon StockSEC:0000950170-25-007545:0
71,704 shares@ US$0.6515.8% of flowCommon SharesSEC:0001415889-25-000386:0
13,797 sharesCommon StockSEC:0000950170-24-115920:0
13,797 sharesCommon StockSEC:0000950170-24-085096:0
163,334 shares0Common SharesSEC:0001415889-24-017691:0
13,797 sharesCommon StockSEC:0000950170-24-046050:0
62,500 sharesCommon StockSEC:0000950170-24-042226:0
150,000 shares@ US$0.919898.5% of flowCommon StockSEC:0001209191-23-055664:0
Ideal exit: 12 Aug 2024 (T+270)
692 shares@ US$1.650.8% of flowCommon StockSEC:0001209191-23-047180:0
132,647 shares0Common StockSEC:0001209191-23-039624:0
691 shares@ US$1.450.7% of flowCommon StockSEC:0001209191-23-031910:0
53,822 shares@ US$20.0056.4% of flowCommon StockSEC:0001385508-23-000075:0
60,000 sharesCommon StockSEC:0001104659-22-103243:0
Ideal exit: 20 Jun 2023 (T+270)
120,000 sharesCommon StockSEC:0001104659-22-102917:0
Ideal exit: 19 Jun 2023 (T+270)
13,500 shares@ US$55.0075.6% of flowCommon StockSEC:0001209191-22-040255:0
36,496 sharesCommon StockSEC:0001104659-22-075927:0
2,000 shares0Common StockSEC:0001385508-22-000090:0
1,663 shares@ US$11.4962.3% of flowCommon StockSEC:0001385508-22-000076:0
Ideal exit: 7 Mar 2023 (T+270)
25 of 37 declarations
About Collard Craig A
Craig A Collard is an executive at OPIANT PHARMACEUTICALS, INC.
